Key result
Among evaluated oxidative stress biomarkers, ischemia modified albumin (IMA) was identified as an independent risk factor for STEMI.
Why the study?
Oxidative stress is closely associated with atherosclerosis and acute coronary syndromes, prompting evaluation of well-known and proportional oxidative stress biomarkers in STEMI patients.
Are oxidative stress biomarkers, including proportional markers like MPO/PON-1 and MPO/HDL-C, elevated in patients with STEMI compared to controls?
Cross-Sectional (n=107)
No
Are oxidative stress biomarkers, including proportional markers like MPO/PON-1 and MPO/HDL-C, elevated in patients with STEMI compared to controls?
Oxidative stress biomarkers, particularly ischemia modified albumin (IMA) and oxidative stress index (OSI), are elevated in STEMI and may play a role in its pathogenesis and short-term prognosis.
Answers are grounded in this paper and cite their sources.
Oxidative stress markers merit prospective validation in STEMI; cross-sectional data leaves open diagnostic or prognostic utility.
Objectives Oxidative stress is closely associated with atherosclerosis and acute coronary syndromes. The purpose of this study was to evaluate well-known and proportional oxidative stress biomarkers in ST-Elevation Myocardial Infarction (STEMI) patients. Methods In this single center, prospective and cross-sectional study, 107 individuals (63 patients) were studied. Total oxidative status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), ischemia modified albumin (IMA), myeloperoxidase (MPO), paraoxonase-1 (PON-1) and arylesterase (AREase) enzyme activities as well as MPO/PON-1, MPO/AREase and MPO/HDL-C ratios were studied. As short-term in-hospital prognosis biomarkers; in-hospital mortality, early systolic dysfunction and spontaneous complete revascularization were investigated. Results Our results indicated that TOS, OSI, IMA, MPO, MPO/PON-1 and MPO/HDL ratios were significantly higher, PON-1 and AREase were significantly lower in STEMI patients compared to the control group. However, in the regression analysis performed by adjusting the differences between the groups, only IMA was found as an independent risk factor (OR=2.711, 95 % CI=1.094–6.719, p=0.031). In terms of in-hospital short-term prognostic biomarkers, a significant relationship was found only between OSI and spontaneous complete revascularization. The OSI value was higher in the group with TIMI grade 3 flow than in the group with TIMI grade 0–2 flow (2.42 [0.81–4.49] vs. 1.63 [0.33–6.07], p=0.016). Conclusions In STEMI patients, both the well-known (TOS, OSI, and MPO) and proportional (MPO/PON-1 and MPO/HDL cholesterol ratios) oxidative stress markers were elevated and can be considered as having a role in the pathogenesis of STEMI.
No takes yet. Share an insight, caveat, or question.
HAMAMCIOĞLU et al. (2023) conducted a cross-sectional in ST-Elevation Myocardial Infarction (STEMI) (n=107). Oxidative stress biomarkers (including IMA, TOS, OSI, MPO) vs. Control group was evaluated on Independent risk factor for STEMI (OR 2.711, 95% CI 1.094-6.719, p=0.031). Among evaluated oxidative stress biomarkers, ischemia modified albumin (IMA) was identified as an independent risk factor for STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: